Skip to main content

What We Do

MTRC has been providing reimbursement, health economic and evidence synthesis services to the medical device and in-vitro diagnostics industry in Europe since 2017. 

Coding, payment mechanism, reimbursement tariffs, the pathway to create or improve reimbursement situation for the technology 

Experience in 34 EU countries, Australia and Canada

Adaptations of global models to EU countries and development of de novo models

Early and full value dossiers for the med tech industry, systematic literature reviews and meta-analyses

General introductory seminars and more than 70 country-specific seminars

Service of monitoring key reimbursement and HTA developments for medical devices, in-vitro diagnostic tests, and digital technologies in Europe and globally

News and insights

To stay up to date, we constantly monitor developments of reimbursement systems in Europe

Subscribe to our newsletter to get bi-weekly updates key reimbursement/HTA news items

Subscribe Subscribe Subscribe Subscribe Subscribe Subscribe

Our free newsletter contains less than 10% of the identified news items. Access our paid services "HTA Alerts" and "Reimbursement Alerts" to access full, customised reports from more than 90 reimbursement and HTA organizations globally

07 Dec 2023

MTRC released an analytical White Paper with a summary of clinical evidence requirements for Interventional Procedures Program at NICE

Health technology assessment plays an important role in market access for medical technologies in England. National Institute for Health and Care Excellence (NICE) is the key HTA organization with several programs dedicated to the assessment of medical technologies. One of the key med tech-related programs at NICE is the Interventional Procedures Program. MTRC developed an analytical White Paper with a summary of clinical evidence requirements for Interventional Procedures Program at NICE.
07 Dec 2023

Recommendations about add-on reimbursement for medical devices in France in November 2023

The French National Authority for Health (HAS) released new recommendations about add-on reimbursement of medical devices and medical aids from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in November 2023. Seven recommendations were published in relation to the registration of medical devices in the List of reimbursable products and services (LPPR). Opinions concern cardiovascular, nephrology and urology, and orthopedic devices, as well as medical aids.

Geography of our projects

MTRC is a provider of multi-country European projects. We have worked on the projects in 34 European countries


MTRC in numbers 

An extremely specialised boutique consultancy with a global impact

Full-time employees
Regular clients from the top 30 med tech companies
Of business comes from Small to Medium-sized Enterprises (SMEs)

Why partner with MTRC?

Be confident in the results

We are accredited by the United Kingdom Accreditation Service (UKAS) as an ISO 9001:2015 certified vendor, specialised in medical technologies market access. Unlike many of our competitors, we dedicate 100% of our time and focus to the area of medical technologies, so that our clients enjoy higher quality services at a lower cost

Avoid the hassle of working with multiple vendors

We specialize in Pan-European projects and worked in 34 countries in Europe. You can save time, effort and money by working with a single experienced vendor vs contracting several consultants individually

Spend less on consulting

We understand the budgetary challenges of the med tech industry and can therefore offer a cost-effective approach to our specialised services. Fourteen percent (14%) of our current business comes from small to medium-sized enterprises (SMEs) – a testament to our unique and personal approach to solve your budgetary challenges

Direct access to senior leadership

Small enough to ensure significant personal attention, and large enough to address your needs, our boutique consultancy guarantees that each project enjoys the attention it deserves with direct access to our senior leaders

Make decisions and advance your business quickly

We appreciate the time-sensitive nature of market access. Being a flexible team, we are not afraid to go beyond regular working hours to meet the high expectations of our clients. For every type of project, we offer the shortest possible turnaround times

Technological coverage of our services

We provide services for major types of medical technologies:

Implantable devices
Interventional procedures
Non-interventional procedures
In-Vitro diagnostics (IVD) tests
Medical aids

Our team has worked on hundreds of reimbursement/HEOR projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, and endoscopy, amongst others.

Thought Leadership

Market Access Monitor

Service of monitoring key reimbursement and HTA developments for medical devices, in-vitro diagnostic tests, and digital technologies in Europe and globally.

Learn more

Free EU reimbursement news and Publications Digest

Bi-weekly newsletter with 10 key reimbursement/HTA news items and summaries of the most important peer-reviewed publications. Access news from as far back as 2017. 

Learn more

Analytical White Papers

Free analytical and research White Papers on the topic of reimbursement, HTA and evidence requirements for medical devices and IVD tests in Europe.

Learn more

Syndicated reports

Since 2017, MTRC has developed syndicated reports on innovative payment schemes, HTA activities in the med tech field, and reimbursement of digital technologies amongst others. See the content and download sample pages.

Learn more

Report on innovative payment schemes for EU association Med Tech Europe

In 2022 Med Tech Europe and MTRC developed a comprehensive report on innovative payment schemes in European countries.

Learn more


MTRC offers several free webinars on the topic of med tech market access.

Learn more

Educational materials on market access

MTRC offers the most comprehensive repository of training presentations on the topic of med tech market access. We offer both general introductory seminars (including pre-recorded webinars) and more than 70 country-specific seminars. 

Learn more

Youtube channel “Market Access Insider”

In 2019 MTRC launched a channel dedicated to the topic of market access for medical devices. See our interviews with different stakeholders from EU countries.

Learn more

Get in touch

Contact us to discuss your needs and learn about our services